$MGHL
MORGAN GROUP HOLDING CO

2023 Q2 Form 10-Q Financial Statement

#000114036123024683 Filed on May 15, 2023

View on sec.gov

Income Statement

Concept 2023 Q2 2023 Q1 2022 Q1
Revenue $469.0K $497.2K $508.8K
YoY Change -1.32% -2.28% -24.97%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $610.3K $511.8K $553.0K
YoY Change 15.16% -7.46% -42.06%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $2.470K $2.572K $2.740K
YoY Change -9.52% -6.13% -3.01%
% of Gross Profit
Operating Expenses $849.0K $773.6K $855.9K
YoY Change 2.71% -9.61% -31.0%
Operating Profit
YoY Change
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income -$380.0K -$276.4K -$347.1K
YoY Change 8.16% -20.36% -38.28%
Income Tax $0.00 $0.00 $0.00
% Of Pretax Income
Net Earnings -$380.0K -$276.4K -$347.1K
YoY Change 8.16% -20.36% -38.28%
Net Earnings / Revenue -81.03% -55.6% -68.22%
Basic Earnings Per Share -$0.63 -$0.46 -$0.58
Diluted Earnings Per Share -$0.63 -$0.46 -$0.58
COMMON SHARES
Basic Shares Outstanding 600.1K 600.1K 600.1K
Diluted Shares Outstanding 600.1K 600.1K 600.1K

Balance Sheet

Concept 2023 Q2 2023 Q1 2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $1.520M $2.351M $2.925M
YoY Change -39.21% -19.62% -25.38%
Cash & Equivalents $1.520M $2.351M $2.925M
Short-Term Investments
Other Short-Term Assets $350.0K $350.0K $350.0K
YoY Change 0.0% 0.0% 75.0%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $2.382M $3.121M $3.706M
YoY Change -28.55% -15.79% -19.74%
LONG-TERM ASSETS
Property, Plant & Equipment $6.729K $9.200K $19.97K
YoY Change -60.95% -53.93% -35.77%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $128.6K $84.02K $148.9K
YoY Change -27.8% -43.58% -35.87%
Total Long-Term Assets $135.3K $93.22K $168.9K
YoY Change -30.72% -44.81% -35.86%
TOTAL ASSETS
Total Short-Term Assets $2.382M $3.121M $3.706M
Total Long-Term Assets $135.3K $93.22K $168.9K
Total Assets $2.517M $3.214M $3.875M
YoY Change -28.67% -17.05% -20.61%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses $1.068M $1.347M $919.2K
YoY Change 13.97% 46.59% 68.96%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $1.087M $1.403M $967.6K
YoY Change 10.45% 45.05% 59.04%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $218.2K
YoY Change -4.07%
Total Long-Term Liabilities $0.00 $0.00 $218.2K
YoY Change -100.0% -100.0% -4.07%
TOTAL LIABILITIES
Total Short-Term Liabilities $1.087M $1.403M $967.6K
Total Long-Term Liabilities $0.00 $0.00 $218.2K
Total Liabilities $1.087M $1.403M $1.186M
YoY Change -8.77% 18.36% 41.87%
SHAREHOLDERS EQUITY
Retained Earnings -$52.46M -$52.08M
YoY Change 1.76%
Common Stock $6.001K $6.001K
YoY Change 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $1.431M $1.811M $2.689M
YoY Change
Total Liabilities & Shareholders Equity $2.517M $3.214M $3.875M
YoY Change -28.67% -17.05% -20.61%

Cashflow Statement

Concept 2023 Q2 2023 Q1 2022 Q1
OPERATING ACTIVITIES
Net Income -$380.0K -$276.4K -$347.1K
YoY Change 8.16% -20.36% -38.28%
Depreciation, Depletion And Amortization $2.470K $2.572K $2.740K
YoY Change -9.52% -6.13% -3.01%
Cash From Operating Activities -$830.9K $65.32K $35.74K
YoY Change 95.83% 82.78% -104.32%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities
YoY Change
NET CHANGE
Cash From Operating Activities -830.9K 65.32K 35.74K
Cash From Investing Activities
Cash From Financing Activities
Net Change In Cash -830.9K 65.32K 35.74K
YoY Change 95.83% 82.78% -104.32%
FREE CASH FLOW
Cash From Operating Activities -$830.9K $65.32K $35.74K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q1 us-gaap Brokerage Commissions Revenue
BrokerageCommissionsRevenue
467272
CY2022Q1 us-gaap Brokerage Commissions Revenue
BrokerageCommissionsRevenue
503738
CY2023Q1 mghl Principal Transactions
PrincipalTransactions
2018
CY2022Q1 mghl Principal Transactions
PrincipalTransactions
46
CY2023Q1 us-gaap Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
31189
CY2023Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
10000000
CY2023Q1 us-gaap Revenues
Revenues
497198
CY2022Q1 us-gaap Revenues
Revenues
508785
CY2022Q1 us-gaap Clearance Fees
ClearanceFees
229649
CY2023Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
221252
CY2022Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
225008
CY2023Q1 us-gaap Occupancy Net
OccupancyNet
45334
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-276437
CY2022Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-347113
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-276437
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-347113
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.46
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.46
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.58
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.58
CY2022Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0
CY2023Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
600090
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
600090
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.58
CY2022Q4 us-gaap Due From Related Parties
DueFromRelatedParties
20190
CY2023Q1 us-gaap Due To Affiliate Current And Noncurrent
DueToAffiliateCurrentAndNoncurrent
38516
CY2022Q4 us-gaap Due To Affiliate Current And Noncurrent
DueToAffiliateCurrentAndNoncurrent
594
CY2023Q1 dei Amendment Flag
AmendmentFlag
false
CY2023Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2023Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001162283
CY2023Q1 us-gaap Due From Related Parties
DueFromRelatedParties
20135
CY2022Q1 us-gaap Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
4939
CY2023Q1 us-gaap Revenue Not From Contract With Customer Other
RevenueNotFromContractWithCustomerOther
755
CY2022Q1 us-gaap Revenue Not From Contract With Customer Other
RevenueNotFromContractWithCustomerOther
154
CY2023Q1 us-gaap Labor And Related Expense
LaborAndRelatedExpense
290510
CY2022Q1 us-gaap Labor And Related Expense
LaborAndRelatedExpense
327992
CY2023Q1 us-gaap Clearance Fees
ClearanceFees
216539
CY2022Q1 us-gaap Occupancy Net
OccupancyNet
73249
CY2023Q1 us-gaap Operating Expenses
OperatingExpenses
773635
CY2022Q1 us-gaap Operating Expenses
OperatingExpenses
855898
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
600090
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
600090
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
600090
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
600090
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
2087054
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-276437
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
1810617
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
3036245
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-347113
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
2689132
CY2023Q1 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
3788
CY2022Q1 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-256555
CY2020Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2020Q2 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
0.01
CY2023Q1 mghl Number Of Nyse Member Firms Through Which All Securities Transactions Are Cleared
NumberOfNYSEMemberFirmsThroughWhichAllSecuritiesTransactionsAreCleared
3
CY2023Q1 mghl Underwriter Payment Receiving Maximum Period
UnderwriterPaymentReceivingMaximumPeriod
P90D
CY2023Q1 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
0
CY2022Q1 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
0
CY2023Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.009
CY2022Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0
CY2023Q1 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-276437
CY2023Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-276437
CY2022Q1 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-347113
CY2022Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-347113
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
600090
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
600090
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.46
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.46
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.58

Files In Submission

Name View Source Status
0001140361-23-024683-index-headers.html Edgar Link pending
0001140361-23-024683-index.html Edgar Link pending
0001140361-23-024683.txt Edgar Link pending
0001140361-23-024683-xbrl.zip Edgar Link pending
brhc20052784_10q.htm Edgar Link pending
brhc20052784_10q_htm.xml Edgar Link completed
brhc20052784_ex31-1.htm Edgar Link pending
brhc20052784_ex31-2.htm Edgar Link pending
brhc20052784_ex32-1.htm Edgar Link pending
brhc20052784_ex32-2.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
mghl-20230331.xsd Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
mghl-20230331_cal.xml Edgar Link unprocessable
mghl-20230331_def.xml Edgar Link unprocessable
mghl-20230331_lab.xml Edgar Link unprocessable
mghl-20230331_pre.xml Edgar Link unprocessable